Choung Hokyung, Reshef Edith R, Tanking Thidarat, Freitag Suzanne K
Department of Ophthalmology, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, Korea.
Ophthalmic Plastic Surgery Service, Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, USA.
Orbit. 2020 Feb;39(1):23-30. doi: 10.1080/01676830.2019.1573434. Epub 2019 Feb 7.
: To present five cases of lower eyelid cicatricial entropion secondary to ocular cicatricial pemphigoid (OCP) successfully repaired with a conjunctival-sparing surgical technique.: The records of one surgeon (SKF) were reviewed to identify patients with lower eyelid cicatricial entropion secondary to OCP who underwent repair with a conjunctival-sparing technique between September 1, 2016 and October 18, 2017. The medical records were reviewed and extracted data included: age, gender, past medical history, current medical and OCP status, clinical examination, details of entropion repair surgery, and outcome.: Five patients (three female, two male) were included with ages ranging from 44 to 93 years. All had biopsy proven OCP, which was in remission at the time of surgery, and all were currently receiving immunomodulatory medications. All patients were symptomatic from cicatricial entropion secondary to OCP and underwent successful lower eyelid entropion repair with a conjunctival-sparing technique described herein, involving infraciliary rotation with suture fixation of the orbicularis muscle to the tarsus. Other contributing mechanisms of eyelid malposition including horizontal eyelid laxity and orbicularis oculi override were addressed simultaneously with lateral tarsal plication or orbicularis muscle debulking, resulting in 100% anatomic success and relief of symptoms with no cases of OCP reactivation, and with good durability with an average 13.9 months follow up (range 6.5-22 months).: Successful repair of lower eyelid cicatricial entropion in immunomodulated patients with OCP can be achieved without disease reactivation using a surgical technique that spares the conjunctiva and lower eyelid retractors.
介绍5例因瘢痕性类天疱疮(OCP)继发的下睑瘢痕性睑内翻,采用保留结膜的手术技术成功修复的病例。回顾一位外科医生(SKF)的记录,以确定2016年9月1日至2017年10月18日期间因OCP继发下睑瘢痕性睑内翻并采用保留结膜技术进行修复的患者。查阅病历并提取的数据包括:年龄、性别、既往病史、当前医疗和OCP状况、临床检查、睑内翻修复手术细节及结果。纳入5例患者(3例女性,2例男性),年龄在44至93岁之间。所有患者活检均证实为OCP,手术时病情处于缓解期,且均在接受免疫调节药物治疗。所有患者均因OCP继发的瘢痕性睑内翻出现症状,并采用本文所述的保留结膜技术成功进行了下睑睑内翻修复,包括睫毛下旋转并将眼轮匝肌缝合固定于睑板。同时通过外侧睑板折叠或眼轮匝肌减容处理眼睑位置异常的其他相关机制,如水平眼睑松弛和眼轮匝肌过度覆盖,实现了100%的解剖学成功及症状缓解,无OCP再激活病例,随访平均13.9个月(范围6.5 - 22个月),效果持久。对于接受免疫调节治疗的OCP患者,使用保留结膜和下睑牵开器的手术技术可成功修复下睑瘢痕性睑内翻,且不会导致疾病再激活。